Other
Trauma
0
Pipeline Programs↗
11
Active Trials↗
3
Companies Involved↗
Trauma is an early-stage landscape with 0 programs across 3 companies. The most active players are GSK, Sanofi, Norther Private Collage of Nursing.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
55
clinical trials
Completed31 · 56%
Recruiting8 · 15%
Terminated7 · 13%
Unknown status5 · 9%
Active, not recruiting2 · 4%
Withdrawn1 · 2%
Other1 · 2%
Clinical Trials
Trial Activity
55 trials
Fibrinogen Early In Severe Trauma StudY II
Recruiting·—·Phase 3·NCT05449834·900 enrolled
The Effect of Dronabinol on the Acquisition and Consolidation of Trauma-Associated Memories
Active, not recruiting·—·N/A·NCT04871269·291 enrolled
Identity Oriented Psychotrauma Therapy on Hashimoto in Adults
Completed·—·N/A·NCT04600349·70 enrolled
Page 1 of 4
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)